RLAY - Relay Therapeutics Inc
10.8
0.110 1.019%
Share volume: 7,425,435
Last Updated: 03-11-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$10.69
0.11
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-06-2024 | 11-06-2024 | 02-26-2025 | 05-05-2025 | 11-06-2025 | 02-26-2026 | |
| Cash flow financing | 48.922 M | 1.542 M | 218.889 M | 800.000 K | 0.000 | 17.000 K | 934.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -50.323 M | -18.741 M | 17.644 M | -28.070 M | -30.745 M | -22.377 M | -8.468 M | |
| Net income | -81.387 M | -92.212 M | -88.105 M | -76.004 M | -77.065 M | -74.149 M | -54.890 M | |
| Depreciation | 1.395 M | 1.368 M | 1.367 M | 1.334 M | 1.208 M | 748.000 K | 599.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 10.531 M | 45.550 M | -126.162 M | 28.998 M | 42.465 M | 39.725 M | 35.463 M | |
| Net Borrowings | -717.794 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -1.780 M | 11.000 K | 227.000 K | 0.000 | 384.000 K | -1.000 K | 1.000 K | |
| Cash Change | 749.608 M | -18.741 M | 17.644 M | -28.070 M | -30.745 M | -22.377 M | -8.468 M |